Rare Diseases An Overview of Fibrodysplasia Ossificans Progressiva By Abby Norman Abby Norman LinkedIn Abby Norman is a freelance science writer and medical editor. She is also the author of "Ask Me About My Uterus: A Quest to Make Doctors Believe in Women's Pain (2018)." Learn about our editorial process Updated on January 30, 2020 Medically reviewed by Anita C. Chandrasekaran, MD, MPH Medically reviewed by Anita C. Chandrasekaran, MD, MPH LinkedIn Anita Chandrasekaran, MD, MPH, is board-certified in internal medicine and rheumatology and currently works as a rheumatologist at Hartford Healthcare Medical Group in Connecticut. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Symptoms Causes Diagnosis Treatment Fibrodysplasia Ossificans Progressiva (FOP) is a very rare inherited condition in which the connective tissues of the body including muscles, tendons, and ligaments, are gradually replaced by bone (in a process called ossification). The condition is present at birth but symptoms may not become apparent until early childhood. Ossification may occur randomly or after an injury. Verywell / JR Bee Symptoms While a person is born with FOP, signs and symptoms of ossification may not become noticeable until a child gets a little older and has started to grow. In newborns, the first sign of FOP is a congenital abnormality of the toes. Shortly after birth, medical professionals or parents may notice the infant's big toes are shorter than the other toes, and turned inward. This malformation is seen in all people with FOP and is an important clue for making the diagnosis. Around 50% of people with the condition also have similar congenital malformations in the thumbs—other malformations have been observed as well, such as in the spine. A newborn may also have swelling around their eyes and scalp. In some cases, this swelling may begin while the fetus is still in utero, though the condition is typically not diagnosed until after birth. Most people with FOP will experience the condition's major symptoms for the first time (sometimes referred to as a "flare up") by the age of 10. While the overall rate of the condition's progression is unknown, ossification tends to follow a particular pattern, starting in the neck and working its way down to the shoulders, torso, limbs, and feet. However, since bone formation can be affected by injury (such as breaking an arm) or viral illness (such as influenza), the disease may not strictly follow this progression. The primary symptoms of FOP depend on which parts of the body have become ossified. Tender lumps under the skin (subcutaneous nodules) are common with the condition. Sometimes, a mild fever will precede the formation of these nodules. Most people with FOP will have general symptoms of pain, stiffness, and a progressive lack of mobility as more bone formation occurs. Depending on which parts of the body become ossified, more specific symptoms can include: Trouble eating that may lead to nutritional deficiencies or malnutrition Difficulty speaking Dental problems Difficulty breathing Respiratory infections Hearing impairment Hair loss (alopecia) Anemia Nerve compression or entrapment Right-sided congestive heart failure Curvature of the spine (scoliosis and kyphosis) Sensory abnormalities Mild intellectual disability Neurological symptoms People with FOP may have periods in their lives where they don't experience new bone growth. At other times, it may seem to happen randomly and in the absence of any obvious injury or illness. When ossification occurs in an unusual part of the body (where bone is not typically found) it can lead to fractures. Over time, the formation of new bone and tissue swelling that accompanies this condition can severely affect how well a person is able to move. In most cases, FOP eventually leads to complete immobilization. Many people with the condition will become bedridden by the age of 30. Causes Most FOP cases happen because of a random gene mutation. A person rarely develops the condition because they inherited an abnormal gene from one of their parents, and it doesn't usually run in families. In genetics, this is known as an autosomal dominant disorder. The gene mutation responsible for the condition was identified by researchers at the University of Pennsylvania—they identified a mutation in a bone morphogenetic protein (BMP) receptor gene on chromosome 2 called Activin Receptor Type IA (ACVR1/ALK2). ACVR1 is present in the gene that encodes bone morphogenic proteins which help form and repair the skeleton, starting when an embryo is still forming. Researchers believe the mutation in the gene prevents these receptors from being turned 'off,' which allows uncontrolled bone to form in parts of the body where it normally would not appear throughout a person's life. Diagnosis FOP is very rare. Only a few thousand people are suspected to have the condition and there are only about 900 known patients of this condition in the world—279 of them are in the United States. FOP doesn't appear to be more common in a particular race, and the condition is found about as often in boys as girls. Diagnosing FOP can be difficult. It's not unusual for the condition to initially be misdiagnosed as a form of cancer or a condition called aggressive juvenile fibromatosis. Early in the course of FOP, if tissue is biopsied and examined under a microscope (histologic exam), it may share some similarities with aggressive juvenile fibromatosis. However, with the latter condition, the lesions do not progress to fully formed bone as they do in FOP. This can help a doctor make a distinction between the two. One major diagnostic clue that would lead a doctor to suspect FOP as opposed to another condition is the presence of short, malformed big toes. If a tissue biopsy is unclear, a clinical exam of a child can help a doctor rule out aggressive juvenile fibromatosis. Children with aggressive juvenile fibromatosis do not have the congenital malformation of toes or fingers, but a child with FOP nearly always does. Another condition, progressive osseous heteroplasia, can also be confused with FOP. The key distinction when making the diagnosis is that bone growth in progressive osseous heteroplasia usually begins on the skin, not under it. These osseous plaques on the surface of the skin distinguish the condition from the tender nodules that occur in FOP. Other tests a doctor may use if they suspect FOP include: Thorough medical history and physical exam Radiologic tests like computed tomography (CT) or bone scintigraphy (bone scan) to look for skeletal changes Lab tests to measure alkaline phosphatase levels Genetic testing to look for mutations If FOP is suspected, doctors will generally try to avoid any invasive tests, procedures, or biopsies because trauma usually results in more bone formation in someone with this condition. While the condition doesn't typically run in families, parents who have a child diagnosed with FOP may find genetic counseling helpful. Treatment There is currently no cure for FOP. There is also no definitive or standard course of treatment. The treatments that do exist are not effective for every patient and therefore the primary goal is to treat symptoms and prevent bone growth when possible. While treatment won't stop the progression of the condition, the medical decisions for managing pain and other symptoms associated with FOP will depend on the individual patient's needs. A doctor may recommend trying one or more of the following treatments to improve a patient's quality of life: High-dose Prednisone or another corticosteroid during a flare-up Drugs like Rituximab (typically used to treat rheumatoid arthritis) Iontophoresis, which uses an electric current to deliver medicine through the skin Muscle relaxants Drugs called bisphosphonates that are used to help protect bone density Non-steroidal anti-inflammatory drugs (NSAIDs) Medications to inhibit mast cells which may help reduce inflammation Ossification often occurs randomly and can not be completely prevented, but it also can happen in response to inflammation, injury, and illness. Therefore, recommendations about activity, lifestyle, preventative care, and interventions may be made beginning in childhood. These recommendations may include: Avoiding situations that could result in injury, like playing sports Avoiding invasive medical procedures such as biopsies, dental work, and intramuscular immunizations Prophylactic antibiotics to protect against illness or infection when appropriate Infection prevention measures such as proper hand hygiene to guard against common viral illnesses (such as influenza) and other respiratory viruses as well as complications like pneumonia Occupational and physical therapy Mobility aids and other assistive devices such as walkers or wheelchairs. Other medical devices that can help assist with activities of daily living such as dressing and bathing Medical devices or other safety interventions to help prevent falls, such as when rising from bed or showering Assistance programs as needed as disability increases Psychological and social support for patients and their families Educational support, including special education and home-schooling Genetic counseling for families may be useful Invasive procedures or surgeries to attempt to remove areas of abnormal bone growth are not advised, as the trauma of surgery almost invariably leads to the development of further ossification. If surgery is absolutely necessary, the most minimally-invasive technique possible should be used. Patients with FOP also may require special anesthesia considerations. There have been several clinical trials in recent years with the goal of developing better treatment options for people with FOP. A Word From Verywell FOP is an extremely rare condition where a gene mutation causes the connective tissues of the body, including muscles, tendons, and ligaments, to become gradually replaced by bone (ossification). There is no cure for FOP and diagnosing it can be difficult. Treatment is mostly supportive and the progression of the condition is usually fairly unpredictable. Taking steps to avoid injury and other situations that would increase ossification may help reduce the number of "flares" a person has, but new bone may still form without any clear cause. FOP usually leads to complete immobility, and most people are bed-ridden by age 30. However, there are clinical trials underway that hopefully find better treatment options to improve the quality of life and the outcomes for patients with the condition. What Happens When Bone Grows Inside of Tissue? 9 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. What is FOP? International Fibrodysplasia Ossificans Progressiva Association. Fibrodysplasia ossificans progressiva. National Organization for Rare Disorders. Kaplan FS, Chakkalakal SA, Shore EM. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Disease Models & Mechanisms. 2012;5(6):756-762. doi:10.1242/dmm.010280 Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525-527. doi:/10.1038/ng1783 Pignolo RJ, Hsiao EC, Baujat G, Lapidus D, Sherman A, Kaplan FS. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization. Orphanet J Rare Dis. 2021;16(1):350. doi:10.1186/s13023-021-01983-2 FOP and aggressive juvenile fibromatosis. International Fibrodysplasia Ossificans Progressiva Association. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev. 2013;10 Suppl 2(0 2):437-448. Brennan TA, Lindborg CM, Bergbauer CR, Wang H, Kaplan FS, Pignolo RJ. Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP). Bone. 2018;109:259-266. doi:10.1016/j.bone.2017.08.023 Clinical studies and trials. International Fibrodysplasia Ossificans Progressiva Association. Additional Reading https://www.ifopa.org/ By Abby Norman Abby Norman is a freelance science writer and medical editor. She is also the author of "Ask Me About My Uterus: A Quest to Make Doctors Believe in Women's Pain." See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit